Literature DB >> 11463017

Prophylactic mastectomy for women with BRCA1 and BRCA2 mutations--facts and controversy.

A Eisen, B L Weber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11463017     DOI： 10.1056/NEJM200107193450309

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

2.  Captious certainties: makings, meanings and misreadings of consumer-oriented genetic testing.

Authors:  Norbert W Paul; Mita Banerjee; Susanne Michl
Journal:  J Community Genet       Date:  2013-11-08

3.  Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred.

Authors:  Anita Yeomans Kinney; Sara Ellis Simonsen; Bonnie Jeanne Baty; Diptasri Mandal; Susan L Neuhausen; Kate Seggar; Richard Holubkov; Lindsey Bloor; Ken Smith
Journal:  J Genet Couns       Date:  2006-08       Impact factor: 2.537

4.  The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers.

Authors:  Sharon Galper Grossman
Journal:  Rambam Maimonides Med J       Date:  2015-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.